# Milrinone in Congenital Diaphragmatic Hernia

> **NCT02951130** · PHASE2 · COMPLETED · sponsor: **NICHD Neonatal Research Network** · enrollment: 66 (actual)

## Conditions studied

- Congenital Diaphragmatic Hernia
- Persistent Pulmonary Hypertension of the Newborn
- Hypoxemic Respiratory Failure
- Pulmonary Hypoplasia

## Interventions

- **DRUG:** Milrinone
- **DRUG:** Placebo (5% Dextrose)

## Key facts

- **NCT ID:** NCT02951130
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-24
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-05-19
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951130, "Milrinone in Congenital Diaphragmatic Hernia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02951130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*